Literature DB >> 5676403

Inactivation and phosphorylation of kanamycin by drug-resistant Staphylococcus aureus.

O Doi, M Miyamoto, N Tanaka, H Umezawa.   

Abstract

The cell-free system of clinical isolates of drug-resistant Staphylococcus aureus inactivated kanamycin, and the inactivated product was identified with kanamycin-3'-phosphate, in which the C-3-OH of the 6-amino-6-deoxy-d-glucose moiety of kanamycin was phosphorylated.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676403      PMCID: PMC547641          DOI: 10.1128/am.16.9.1282-1284.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  9 in total

1.  Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor.

Authors:  H Umezawa; M Okanishi; S Kondo; K Hamana; R Utahara; K Maeda; S Mitsuhashi
Journal:  Science       Date:  1967-09-29       Impact factor: 47.728

2.  Chloramphenicol-, dihydrostreptomycin-, and kanamycin-inactivating enzymes from multiple drug-resistant Escherichia coli carrying episome 'R'.

Authors:  S Okamoto; Y Suzuki
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

3.  Isolation of kanamycin and paromamine inactivated by E. coli carrying R factor.

Authors:  S Kondo; M Okanishi; R Utahara; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

4.  Studies on inactivation of kanamycin and resistances of E. coli.

Authors:  M Okanishi; S Kondo; Y Suzuki; S Okamoto; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

5.  Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli.

Authors:  H Umezawa; M Okanishi; R Utahara; K Maeda; S Kondo
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

6.  Biochemical studies on the activity of thiophenicol.

Authors:  T Nishimura; H Yamaguchi; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1966-07       Impact factor: 2.649

7.  The enzymatic acetylation of chloramphenicol by extracts of R factor-resistant Escherichia coli.

Authors:  W V Shaw
Journal:  J Biol Chem       Date:  1967-02-25       Impact factor: 5.157

8.  Basis of chloramphenicol resistance in naturally isolated resistant staphylococci.

Authors:  Y Suzuki; S Okamoto; M Kono
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa.

Authors:  O Doi; M Ogura; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09
  9 in total
  12 in total

Review 1.  Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance.

Authors:  R W Lacey
Journal:  Bacteriol Rev       Date:  1975-03

Review 2.  Genetic basis, epidemiology, and future significance of antibiotic resistance in Staphylococcus aureus: a review.

Authors:  R W Lacey
Journal:  J Clin Pathol       Date:  1973-12       Impact factor: 3.411

3.  Functional and kinetic analysis of the phosphotransferase CapP conferring selective self-resistance to capuramycin antibiotics.

Authors:  Zhaoyong Yang; Masanori Funabashi; Koichi Nonaka; Masahiko Hosobuchi; Tomoyuki Shibata; Pallab Pahari; Steven G Van Lanen
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

4.  Microbial transformation of antibiotics: phosphorylation of clindamycin by Streptomyces coelicolor Müller.

Authors:  J H Coats; A D Argoudelis
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

5.  New plasmid-mediated nucleotidylation of aminoglycoside antibiotics in Staphlococcus aureus.

Authors:  F Le Goffic; A Martel; M L Capmau; B Baca; P Goebel; H Chardon; C J Soussy; J Duval; D H Bouanchaud
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

6.  Isolation and characterization of a kanamycin resistance plasmid from Staphylococcus aureus.

Authors:  P W Stiffler; H M Sweeney; M Schneider; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

7.  Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains.

Authors:  F Kobayashi; M Yamaguchi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

8.  Lividomycin resistance in staphylococci by enzymatic phosphorylation.

Authors:  F Kobayashi; T Koshi; J Eda; Y Yoshimura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

9.  Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa.

Authors:  O Doi; M Ogura; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09

10.  Antibacterial activity of lividomycin toward R factor-resistant strains of Escherichia coli.

Authors:  M Yamaguchi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.